Medicare Enrolled
Dr. Tracey Evans, MD
Hematology & Oncology · East Norriton, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Evans from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Evans?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Evans
Dr. Tracey Evans is a hematology & oncology specialist in East Norriton, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Evans performed 128,479 Medicare services across 1,898 unique beneficiaries.
Between the years covered by Open Payments, Dr. Evans received a total of $514,490 from 70 pharmaceutical and/or device companies across 956 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Evans is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in PA
$514,490 industry payments
Medicare Practice Summary
Medicare Utilization ↗128,479
Medicare services
Top 3% in PA for hematology & oncology
1,898
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,424 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
77,250 | $1 | $2 |
| Pembrolizumab injection (Keytruda) | 17,200 | $43 | $65 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
10,340 | $6 | $18 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,950 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 4,740 | $19 | $35 |
| Pemetrexed injection, 10 mg Administration of a 10 mg dose of pemetrexed medication via injection. |
3,578 | $7 | $65 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,476 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 920 | $1 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $102 | $150 |
| Injection, granisetron hydrochloride, 100 mcg | 630 | $0 | $7 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
459 | $12 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $70 | $125 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
421 | $2 | $6 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
326 | $143 | $200 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
316 | $25 | $90 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
306 | $110 | $325 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
223 | $98 | $132 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
158 | $146 | $255 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
125 | $53 | $175 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
124 | $13 | $65 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
96 | $61 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
94 | $64 | $90 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
74 | $55 | $160 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
72 | $40 | $60 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
65 | $24 | $85 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
63 | $1 | $3 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
60 | $48 | $150 |
| New patient office visit, complex (60-74 min) | 57 | $166 | $275 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
56 | $17 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $137 | $250 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
49 | $1 | $10 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
39 | $21 | $65 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
60.8% high complexity
37.5% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$514,490
Total received (2018-2024)
Avg $73,499/year across 7 years
Top 1% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
956
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$481,302 (93.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,562 (4.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,626 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$31,295
2023
$54,617
2022
$57,388
2021
$66,693
2020
$93,939
2019
$141,272
2018
$69,285
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$15,705
JAZZ PHARMACEUTICALS INC.
$6,311
Mirati Therapeutics, Inc.
$4,646
E.R. Squibb & Sons, L.L.C.
$2,993
Novartis Pharmaceuticals Corporation
$157
PFIZER INC.
$143
ABBVIE INC.
$141
Merck Sharp & Dohme LLC
$140
Incyte Corporation
$114
Astellas Pharma US Inc
$109
Alexion Pharmaceuticals, Inc.
$83
GENZYME CORPORATION
$74
Eisai Inc.
$65
Daiichi Sankyo Inc.
$63
Karyopharm Therapeutics Inc.
$58
Takeda Pharmaceuticals U.S.A., Inc.
$50
Janssen Biotech, Inc.
$48
SOBI, INC
$42
GlaxoSmithKline, LLC.
$35
Gilead Sciences, Inc.
$32
PROGENICS PHARMACEUTICALS, INC.
$29
Blueprint Medicines Corporation
$26
Bayer Healthcare Pharmaceuticals Inc.
$25
Kite Pharma, Inc.
$24
ARRAY BIOPHARMA INC
$23
Rigel Pharmaceuticals, Inc.
$22
Exelixis Inc.
$21
Tolmar, Inc.
$21
Genentech USA, Inc.
$20
Sumitomo Pharma America, Inc.
$20
Celgene Corporation
$19
Tempus AI, Inc
$19
Janssen Pharmaceuticals, Inc
$18
Top 3 companies account for 85.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$293,750
Genentech USA, Inc.
$81,885
JAZZ PHARMACEUTICALS INC.
$56,588
Mirati Therapeutics, Inc.
$29,906
E.R. Squibb & Sons, L.L.C.
$18,954
Merck Sharp & Dohme Corporation
$17,374
Novocure Inc.
$5,417
Regeneron Healthcare Solutions, Inc.
$1,935
PFIZER INC.
$743
Novartis Pharmaceuticals Corporation
$571
Seagen Inc.
$560
Celgene Corporation
$560
Incyte Corporation
$384
Takeda Pharmaceuticals U.S.A., Inc.
$379
Daiichi Sankyo Inc.
$368
Lilly USA, LLC
$342
Astellas Pharma US Inc
$288
GENZYME CORPORATION
$280
Amgen Inc.
$275
Merck Sharp & Dohme LLC
$271
ABBVIE INC.
$265
Pharmacyclics LLC, An AbbVie Company
$218
Eisai Inc.
$213
Janssen Biotech, Inc.
$209
Karyopharm Therapeutics Inc.
$158
Seattle Genetics, Inc.
$146
Alexion Pharmaceuticals, Inc.
$134
EISAI INC.
$128
Gilead Sciences, Inc.
$127
Blueprint Medicines Corporation
$122
Foundation Medicine, Inc.
$106
Pharmacyclics LLC, an AbbVie Company
$101
Pharmacosmos Therapeutics Inc.
$96
Taiho Oncology, Inc.
$94
Stemline Therapeutics Inc.
$90
SOBI, INC
$84
G1 Therapeutics, Inc.
$79
ARRAY BIOPHARMA INC
$79
Octapharma USA, Inc.
$76
PUMA BIOTECHNOLOGY, INC.
$74
TESARO, Inc.
$69
Exelixis Inc.
$68
Kite Pharma, Inc.
$66
BeiGene USA, Inc.
$65
Janssen Pharmaceuticals, Inc
$56
Bayer Healthcare Pharmaceuticals Inc.
$55
GlaxoSmithKline, LLC.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Bayer HealthCare Pharmaceuticals Inc.
$49
Myriad Genetic Laboratories, Inc.
$42
Teva Pharmaceuticals USA, Inc.
$41
Sobi, Inc
$40
Tolmar, Inc.
$39
Myovant Sciences Inc.
$36
Rigel Pharmaceuticals, Inc.
$35
PROGENICS PHARMACEUTICALS, INC.
$29
AbbVie, Inc.
$28
Telix Pharmaceuticals
$26
PharmaEssentia USA Corporation
$23
Dova Pharmaceuticals
$22
Sumitomo Pharma America, Inc.
$20
Amneal Pharmaceuticals LLC
$19
Tempus AI, Inc
$19
Clovis Oncology, Inc.
$18
Dendreon Pharmaceuticals LLC
$18
EUSA Pharma (US) LLC
$17
Coherus Biosciences Inc.
$16
AMAG Pharmaceuticals, Inc.
$15
TerSera Therapeutics LLC
$15
AbbVie Inc.
$13
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYLARIFY · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · REBLOZYL · RETEVMO · ROZLYTREK · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tarceva · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in PA.
Geographic Context
Hematology & oncology specialists within 10 mi
270
Per 100K population
31.4
County median income
$111,521
Nearest hospital
VALLEY FORGE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Evans is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with speaking/promotional industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Evans experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Evans performed 77,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Evans receive payments from pharmaceutical companies?
Yes. Dr. Evans received a total of $514,490 from 70 companies across 956 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Evans's costs compare to other hematology & oncology specialists in East Norriton?
Dr. Evans's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Evans) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in East Norriton
Browse hematology & oncology specialists in East Norriton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology